Acutoxbase, an innovative database for in vitro acute toxicity studies.

Acutoxbase is as an internet-based database developed for coherent management of all information relevant to the EU integrated project 'A-Cute-Tox' (www.acutetox.org), which aims to optimise and prevalidate an in vitro testing strategy for predicting acute human toxicity. The database consists of two principal parts for archiving in vitro and in vivo data, respectively. The in vitro part, designed following the principles of Good Cell Culture Practice (GCCP), provides a standard format for collection of in vitro data, together with detailed descriptions of methodologies (Standard Operating Procedures, SOPs), generated by research laboratories participating in the project. In the course of the study 97 reference chemicals were tested in approximately 100 in vitro assays, including models for general acute cytotoxicity, metabolism-mediated toxicity, biokinetics, haemato-, immuno-, neuro-, nephro-, and hepatotoxicity. The in vivo part compiles mammalian acute toxicity studies derived from published literature and human acute poisoning cases available from clinical reports. The database has proven to be a useful tool for a quality controlled transfer and organisation of large in vitro and in vivo toxicological data sets. At present time, Acutoxbase is under continuous development, and it will be available for the broad circles of toxicologists and physicians in a near future.

[1]  Michael Balls,et al.  The Role of Prevalidation in the Development, Validation and Acceptance of Alternative Methods , 1995 .

[2]  E Walum,et al.  MEIC Evaluation of Acute Systemic Toxicity: Part V. Rodent and Human Toxicity Data for the 50 Reference Chemicals. , 1998, Alternatives to laboratory animals : ATLA.

[3]  Valérie Zuang,et al.  A Modular Approach to the ECVAM Principles on Test Validity , 2004, Alternatives to laboratory animals : ATLA.

[4]  Antonio Chana,et al.  CODES/neural network model: A useful tool for in silico prediction of oral absorption and blood-brain barrier permeability of structurally diverse drugs , 2004 .

[5]  Michael Balls,et al.  Guidance on Good Cell Culture Practice , 2005, Alternatives to laboratory animals : ATLA.

[6]  Hans Raabe,et al.  A Database of IC50 Values and Principal Component Analysis of Results from Six Basal Cytotoxicity Assays, for Use in the Modelling of the In Vivo and In Vitro Data of the EU ACuteTox Project a , 2008, Alternatives to laboratory animals : ATLA.

[7]  Michael Balls,et al.  Report and Recommendations of the CAAT 1 /ERGATT 2 Workshop on the Validation of Toxicity Test Procedures 3 , 1990 .

[8]  M. Sjöström,et al.  Estimation of human blood LC50 values for use in modeling of in vitro-in vivo data of the ACuteTox project. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  Spielmann Horst,et al.  Practical Aspects of the Validation of Toxicity Test Procedures , 1995 .

[10]  C Clemedson,et al.  Overview of the Final MEIC Results: I. The In Vitro--In Vitro Evaluation. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  Sebastian Hoffmann,et al.  Estimation of acute oral toxicity using the No Observed Adverse Effect Level (NOAEL) from the 28 day repeated dose toxicity studies in rats. , 2009, Regulatory toxicology and pharmacology : RTP.

[12]  U. Tillmann,et al.  A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. , 1997, Regulatory toxicology and pharmacology : RTP.

[13]  Andrew Worth,et al.  The Registry of Cytotoxicity: Toxicity Testing in Cell Cultures to Predict Acute Toxicity (LD50) and to Reduce Testing in Animals 1 , 2003, Alternatives to laboratory animals : ATLA.